CAPSTONE INVESTMENT ADVISORS, LLC - CARDLYTICS INC ownership

CARDLYTICS INC's ticker is and the CUSIP is 14161WAB1. A total of 19 filers reported holding CARDLYTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
CAPSTONE INVESTMENT ADVISORS, LLC ownership history of CARDLYTICS INC
ValueSharesWeighting
Q3 2023$12,511,296
+10.1%
20,160,0000.0%0.06%0.0%
Q2 2023$11,366,208
+31.9%
20,160,0000.0%0.06%
+27.3%
Q1 2023$8,618,400
+0.3%
20,160,000
+1.5%
0.04%
-30.2%
Q4 2022$8,589,450
-14.6%
19,860,000
+16.8%
0.06%
+3.3%
Q3 2022$10,056,000
-11.1%
17,000,000
+13.3%
0.06%
+10.9%
Q2 2022$11,316,000
+11.3%
15,000,000
+50.0%
0.06%
+96.4%
Q1 2022$10,165,000
-8.8%
10,000,0000.0%0.03%
+47.4%
Q4 2021$11,144,00010,000,0000.02%
Other shareholders
CARDLYTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
GUARDIAN POINT CAPITAL, LP 5,000,000$5,149,0001.88%
LINDEN ADVISORS LP 65,612,000$66,940,0000.42%
WOLVERINE ASSET MANAGEMENT LLC 38,478,000$39,110,0000.38%
Teton Advisors, Inc. 1,030,000$1,061,0000.18%
683 Capital Management, LLC 2,000,000$2,040,0000.11%
Nicholas Investment Partners, LP 1,385,000$1,401,0000.10%
GABELLI FUNDS LLC 6,920,000$7,128,0000.05%
CAPSTONE INVESTMENT ADVISORS, LLC 10,000,000$10,165,0000.03%
Citadel Advisors 98,500,000$100,325,0000.02%
GAMCO INVESTORS, INC. ET AL 300,000$309,0000.00%
View complete list of CARDLYTICS INC shareholders